Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders

作者: Borcherng Hong , Bruno Tse , Sepehr Sarshar

DOI:

关键词:

摘要: The present invention is directed to compounds having the structure (I) wherein R1, R2, R3, R4, R5 and m are as defined herein. of this novel therapeutic agents for treatment cancer, metabolic diseases skin disorders in mammalian subjects. These also useful modulators gene expression. They exert their activity by interfering with certain cellular signal transduction cascades. thus regulating cell differentiation cycle processes that controlled or regulated various hormones cytokines. In particular, relates induce apoptosis cancer cells therefore may be used prevention including advanced cancers pre-cancerous cells. discloses pharmaceutical compositions methods disease mammals.

参考文章(46)
Margherita Cantorna, John Vanden Heuvel, Avery August, PPAR-gamma ligands in the treatment of asthma and allergies ,(2003)
Jan Zielinski, Robert A. Sanchez, Sheldon S. Hendler, Water soluble pro-drugs of propofol ,(1998)
Subramanian Marappan, Sepehr Sarshar, Cris Davenport, Ph sensitive prodrugs of 2,6-diisopropylphenol ,(2004)
Braham Shroot, Jean-Michel Bernardon, Jacques Eustache, Benzonaphthalene derivatives and compositions ,(1986)
Anne Marinier, Fred C. Zusi, Anna Ericsson, Compounds having retinoid-like activity ,(2002)
Kwee Hyun Suh, Gwan Sun Lee, Nam Du Kim, Mi Ra Halla Apt. Seong, Method of preparing clarithromycin ,(2000)
Sadafumi Omura, Shigeo Morimoto, Yoshiaki Watanabe, Novel erythromycin compounds ,(1981)
Richard Lewanczuk, Gilles Caille, Robert T. Foster, Method of using deuterated calcium channel blockers ,(2001)